Rejection of immunogenic tumor clones is limited by clonal fraction
Tumors often co-exist with T cells that recognize somatically mutated peptides presented by cancer cells on major histocompatibility complex I (MHC-I). However, it is unknown why the immune system fails to eliminate immune-recognizable neoplasms before they manifest as frank disease. To understand t...
Main Authors: | Ron S Gejman, Aaron Y Chang, Heather F Jones, Krysta DiKun, Abraham Ari Hakimi, Andrea Schietinger, David A Scheinberg |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2018-11-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/41090 |
Similar Items
-
Anti-Tumour Promoting Activity of Selected Malaysian Vegetables and Fruits, and Identification of Anti-Tumour Promoting and Antioxidant Compounds from Coleus Tuberosus, Benth (Ubi Kemili)
by: Lim, Yang Mooi
Published: (2002) -
A peptide puzzle
by: Jian Guan, et al.
Published: (2018-12-01) -
Unveiling the novel immune and molecular signatures of ovarian cancer: insights and innovations from single-cell sequencing
by: Zhongkang Li, et al.
Published: (2023-11-01) -
Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications
by: George D. Cresswell, et al.
Published: (2016-07-01) -
Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling
by: Pei-Yu Chen, et al.
Published: (2021-07-01)